Skip to main content
. 2018 Feb 5;13(2):e0192448. doi: 10.1371/journal.pone.0192448

Table 4. Association of alcohol consumption with hepatic fat fraction (HFF) and fatty liver disease (HFF≥5.56%).

Alcohol consumption HFF unadjusted
β (95% CI)
p-value adjusted
β* (95% CI)
p-value FLD
Prevalence
unadjusted
OR (95% CI)
p-value adjusted
OR* (95% CI)
p-value
1H-MRS 1H-MRS
Non-drinker Ref. Ref. 46.2% 1 1
Moderate drinker 0.86 (-1.12; 2.83) 0.395 1.54 (-0.07; 3.16) 0.061 49.3% 1.13 (0.69; 1.86) 0.621 1.46 (0.74; 2.89) 0.271
Heavy drinker 2.54 (0.19; 4.88) 0.034 2.99 (1.01; 4.96) 0.003 62.5% 1.94 (1.07; 3.53) 0.029 3.05 (1.33; 6.99) 0.008
MRI MRI
Non-drinker Ref. Ref. 40.7% 1 1
Moderate drinker 0.95 (-1.13; 3.03) 0.371 1.75 (0.00; 3.50) 0.050 42.0% 1.05 (0.64; 1.74) 0.835 1.36 (0.69; 2.67) 0.370
Heavy drinker 1.88 (-0.59; 4.34) 0.136 2.49 (0.35; 4.63) 0.023 50.0% 1.46 (0.81; 2.64) 0.210 1.97 (0.89; 4.36) 0.095

β-coefficients are from linear regression, OR odds ratios are from logistic regression, CI confidence interval

*adjusted for age, sex, BMI, hypertension, diabetes mellitus and smoking status.

Significant values are shown in bold.